A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Eczema is one of those skin conditions that can sneak up on anyone, turning what should be simple daily routines into a bit ...

Nektar Therapeutics stock launched Tuesday after the biotech company hit every goal in a midstage study of its eczema ...

Discover life-changing eczema treatments and remedies that provide real relief. From prescription breakthroughs to natural ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

Nektar reported positive Phase 2b trial data for rezpegaldesleukin in atopic dermatitis, showing strong efficacy and a ...

The Food and Drug Administration in February granted fast track designation for rezpegaldesleukin to treat adults and pediatric patients 12 years and up with moderate to severe atopic dermatitis, the ...

A team led by the University of Exeter, and including researchers from King's College London, has been awarded a £3.3 million ...

An irritating skin condition is flaring up for a third of Australians trying to keep warm this winter, made worse by heaters, woollen jumpers and long, hot showers.